Evidence map›Paper›PMID 25836671›Full record

ArticlePloS one2015

Comparative genomic analysis of two novel sporadic Shiga toxin-producing Escherichia coli O104:H4 strains isolated 2011 in Germany.

Erhard Tietze, Piotr Wojciech Dabrowski, Rita Prager, Aleksandar Radonic, Angelika Fruth, Philipp Auraß, Andreas Nitsche, Martin Mielke, Antje Flieger

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Genomic Analysis of a Hybrid Enteroaggregative HemorrhagicAntibiotics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Erhard TietzeDepartment of Infectious Diseases, Division of Enteropathogenic Bacteria and Legionella, National Reference Centre for Salmonella and other Bacterial Enteric Pathogens, Wernigerode Branch of Robert Koch-Institute, Berlin, Germany.
Piotr Wojciech DabrowskiCentre for Biological Threats and Special Pathogens, Robert Koch-Institute, Berlin, Germany.
Rita PragerDepartment of Infectious Diseases, Division of Enteropathogenic Bacteria and Legionella, National Reference Centre for Salmonella and other Bacterial Enteric Pathogens, Wernigerode Branch of Robert Koch-Institute, Berlin, Germany.
Aleksandar RadonicCentre for Biological Threats and Special Pathogens, Robert Koch-Institute, Berlin, Germany.
Angelika FruthDepartment of Infectious Diseases, Division of Enteropathogenic Bacteria and Legionella, National Reference Centre for Salmonella and other Bacterial Enteric Pathogens, Wernigerode Branch of Robert Koch-Institute, Berlin, Germany.
Philipp AuraßDepartment of Infectious Diseases, Division of Enteropathogenic Bacteria and Legionella, National Reference Centre for Salmonella and other Bacterial Enteric Pathogens, Wernigerode Branch of Robert Koch-Institute, Berlin, Germany.
Andreas NitscheCentre for Biological Threats and Special Pathogens, Robert Koch-Institute, Berlin, Germany.
Martin MielkeDepartment of Infectious Diseases, Robert Koch-Institute, Berlin, Germany.
Antje FliegerDepartment of Infectious Diseases, Division of Enteropathogenic Bacteria and Legionella, National Reference Centre for Salmonella and other Bacterial Enteric Pathogens, Wernigerode Branch of Robert Koch-Institute, Berlin, Germany.
Robert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large outbreak of gastrointestinal disease occurred in 2011 in Germany which resulted in almost 4000 patients with acute gastroenteritis or hemorrhagic colitis, 855 cases of a hemolytic uremic syndrome and 53 deaths. The pathogen was an uncommon, multiresistant Escherichia coli strain of serotype O104:H4 which expressed a Shiga toxin characteristic of enterohemorrhagic E. coli and in addition virulence factors common to enteroaggregative E. coli. During post-epidemic surveillance of Shiga toxin-producing E. coli (STEC) all but two of O104:H4 isolates were indistinguishable from the epidemic strain. Here we describe two novel STEC O104:H4 strains isolated in close spatiotemporal proximity to the outbreak which show a virulence gene panel, a Shiga toxin-mediated cytotoxicity towards Vero cells and aggregative adherence to Hep-2 cells comparable to the outbreak strain. They differ however both from the epidemic strain and from each other, by their antibiotic resistance phenotypes and some other features as determined by routine epidemiological subtyping methods. Whole genome sequencing of these two strains, of ten outbreak strain isolates originating from different time points of the outbreak and of one historical sporadic EHEC O104:H4 isolate was performed. Sequence analysis revealed a clear phylogenetic distance between the two variant strains and the outbreak strain finally identifying them as epidemiologically unrelated isolates from sporadic cases. These findings add to the knowledge about this emerging pathogen, illustrating a certain diversity within the bacterial core genome as well as loss and gain of accessory elements. Our results do also support the view that distinct new variants of STEC O104:H4 repeatedly might originate from yet unknown reservoirs, rather than that there would be a continuous diversification of a single epidemic strain established and circulating in Germany after the large outbreak in 2011.

Indexed as

Shiga-Toxigenic Escherichia coliAnimalsBacterial AdhesionChlorocebus aethiopsDisease OutbreaksDNA, BacterialEscherichia coli InfectionsGenome, BacterialGermanyHep G2 CellsHumansMolecular Sequence DataPhylogenyPlasmidsPolymorphism, Single NucleotideSequence Analysis, DNADNA, Bacterial

Identifiers

PMID25836671
PMCPMC4383531
OpenAlexW2000589404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.